Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book

IJ Pharmaceutical Research

Home
Current IssueAll IssuesIn PressAccepted Manuscripts
SearchInstructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Molecularly targeted therapy and immunotherapy in leukemias

- Cousin E. , et al.

2. Synergistic Enhancement of Chemotherapy-Induced Cell Death and Antitumor Efficacy against Tumoral T-Cell Lymphoblasts by IMMUNEPOTENT CRP

- Rivera-Lazarín A.L. , et al.

3. SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances

- Song J. , et al.

4. Systematic molecular profiling of acute leukemia cancer stem cells allows identification of druggable targets

- Salavaty A. , et al.

5. Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects

- Kośmider K. , et al.

6. The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia

- Sin C.F. , et al.

7. The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies

- Simioni C. , et al.

8. Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review

- Lin N. , et al.